Bank Of New York Mellon Corp Organon & Co. Transaction History

Bank Of New York Mellon Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$23.31 - $28.61 $128 Million - $157 Million	5,494,292 New	5,494,292 $154 Million
Q3 2022 Nov 14, 2022	BUY	$23.4 - $34.25 $19.5 Million - $28.6 Million	834,392 Added 10.14%	9,066,304 $212 Million
Q2 2022 Aug 15, 2022	SELL	$31.66 - $38.9 $6.27 Million - $7.7 Million	-198,044 Reduced 2.35%	8,231,912 $278 Million
Q1 2022 May 11, 2022	BUY	$30.45 - $39.36 $3.04 Million - $3.93 Million	99,856 Added 1.2%	8,429,956 $294 Million
Q4 2021 Feb 11, 2022	BUY	$28.67 - $37.13 $86.9 Million - $113 Million	3,031,313 Added 57.21%	8,330,100 $254 Million
Q3 2021 Nov 12, 2021	BUY	$28.63 - $35.64 $30.3 Million - $37.7 Million	1,058,652 Added 24.97%	5,298,787 $174 Million
Q2 2021 Aug 11, 2021	BUY	$28.45 - $38.0 $121 Million - $161 Million	4,240,135 New	4,240,135 $128 Million

790

201M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $4.17B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.